Agilent Technologies (A)

$153.84 -3.85 (-2.44%)
Market Cap 43.80B
Revenue (ttm) 6.95B
Net Income (ttm) 1.30B
EPS (ttm) N/A
PE Ratio 26.64
Forward PE 25.58
Profit Margin 18.75%
Debt to Equity Ratio 0.43
Volume 2,966,271
Avg Vol 2,191,170
Day's Range N/A - N/A
Shares Out 282.43M
Stochastic %K 63%
Beta 1.25
Analysts Strong Sell
Price Target $160.00

Company Profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufact...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 800 227 9770
Address:
5301 Stevens Creek Boulevard, Santa Clara, United States
Stocktwits52wHighs
Stocktwits52wHighs Aug. 27 at 4:31 PM
$A printed a new 52-week high today
0 · Reply
runitback349
runitback349 Aug. 27 at 2:08 PM
$A look at the monthly chart. Crazy set-up if it breaks out of the range
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 27 at 12:22 PM
$A (+2.1% pre) Agilent shares rise as strong Q3 results and improving demand support guidance upgrade https://ooc.bz/l/112464
0 · Reply
parcha
parcha Aug. 27 at 12:17 AM
Stocks making the biggest moves after hours: Nvidia, Salesforce, CrowdStrike, Urban Outfitters and more $A $IHI Agilent Technologies — The medical technology stock jumped 4% on a stronger-than-expected revenue report for its third quarter. Agilent said it brought in $1.88 billion in revenue, while analysts polled by FactSet forecast $1.84 billion, per FactSet. https://www.cnbc.com/2026/08/26/stocks-making-the-biggest-moves-after-hours-nvda-crm-crwd-urbn-and-more.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 · Reply
DonCorleone77
DonCorleone77 Aug. 26 at 11:52 PM
$VEEV $NTNX $OOMA $A $NVDA AFTER-HOURS MOVERS: Currently Higher After Earnings: - Okta (OKTA) up 20.5% - Salesforce (CRM) up 13.0% - Lantronix (LTRX) up 13.8% - Phibro Animal Health Corporation (PAHC) up 8.5% - CrowdStrike Holdings (CRWD) up 10.0% - Veeva Systems (VEEV) up 9.0% - Nutanix (NTNX) up 6.3% - Ooma, Inc. (OOMA) up 4.3% - Agilent Technologies (A) up 3.2% - NVIDIA (NVDA) up 4.3% - Everpure, Inc. (P) up 3.1% Currently Also Higher: - Tenable Holdings (TENB) up 7.4% after admission into S&P SmallCap 600 index - Funko (FNKO) up 6.3% after insider buy Currently Lower After Earnings: - HP Inc. (HPQ) down 9.1% - Urban Outfitters, Inc. (URBN) down 2.8% - Synopsys (SNPS) down 1.1% Currently Also Lower: - Wendy's Company (WEN) down 13.2% after Reuters report Trian is backing away from bid.
1 · Reply
Estimize
Estimize Aug. 26 at 10:57 PM
$A reported 1.62 EPS and 1,878 revenue for Q3. http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=A&utm_medium=ac
0 · Reply
EarningsInsider
EarningsInsider Aug. 26 at 9:46 PM
https://www.marketbeat.com/earnings/reports/2026-8-26-agilent-technologies-inc-stock/ $A Agilent Technologies Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 26 at 9:40 PM
$A Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $1.62 up 18.25% YoY • Reported revenue of $1.88B up 8.06% YoY • For fiscal year 2026, Agilent expects revenue between $7.49B and $7.51B, non-GAAP operating margin expansion over 130 basis points at midpoint, and non-GAAP EPS of $6.18 to $6.21.
0 · Reply
flychicken1991
flychicken1991 Aug. 26 at 8:54 PM
$A Positive (86%): Agilent's stock is likely to face upward price pressure as investors incorporate stronger reported demand, above-consensus quarterly results, and higher full-year guidance into forward earnings expectations. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/0af578bd4c16288a/a-agilent-technologies-beats-estimates-raises-guidance-on-strong-demand?utm_source=stocktwits&utm_medium=story_url
0 · Reply
DonCorleone77
DonCorleone77 Aug. 26 at 8:13 PM
$A Agilent raises FY26 EPS view to $6.18-$6.21, consensus $6.06 Raises FY26 revenue view to $7.49B-$7.51B, consensus $7.45B. Prior FY26 EPS guidance was $6.00-$6.10, revenue $7.39B-$7.49B.
0 · Reply
Latest News on A
Agilent price target raised to $180 from $160 at Wells Fargo

2026-08-27T20:00:14.000Z - 1 day ago

Agilent price target raised to $180 from $160 at Wells Fargo

Agilent price target raised to $175 from $150 at Barclays

2026-08-27T15:21:04.000Z - 1 day ago

Agilent price target raised to $175 from $150 at Barclays

Agilent price target raised to $185 from $155 at RBC Capital

2026-08-27T12:50:12.000Z - 1 day ago

Agilent price target raised to $185 from $155 at RBC Capital

Agilent price target raised to $180 from $155 at TD Cowen

2026-08-27T12:45:56.000Z - 1 day ago

Agilent price target raised to $180 from $155 at TD Cowen

Agilent price target raised to $172 from $148 at Evercore ISI

2026-08-27T11:50:42.000Z - 1 day ago

Agilent price target raised to $172 from $148 at Evercore ISI

Agilent price target raised to $180 from $155 at Bernstein

2026-08-27T11:40:34.000Z - 1 day ago

Agilent price target raised to $180 from $155 at Bernstein

Agilent price target raised to $180 from $155 at Bernstein

2026-08-27T11:40:27.000Z - 1 day ago

Agilent price target raised to $180 from $155 at Bernstein

Agilent price target raised to $190 from $180 at JPMorgan

2026-08-27T11:20:20.000Z - 1 day ago

Agilent price target raised to $190 from $180 at JPMorgan

Agilent price target raised to $175 from $155 at Goldman Sachs

2026-08-27T11:15:24.000Z - 1 day ago

Agilent price target raised to $175 from $155 at Goldman Sachs

Agilent price target raised to $190 from $185 at Citi

2026-08-27T10:56:40.000Z - 1 day ago

Agilent price target raised to $190 from $185 at Citi

Agilent price target raised to $180 from $170 at Stifel

2026-08-27T10:45:15.000Z - 1 day ago

Agilent price target raised to $180 from $170 at Stifel

Agilent price target raised to $180 from $155 at BofA

2026-08-27T10:35:22.000Z - 1 day ago

Agilent price target raised to $180 from $155 at BofA

Agilent raises annual profit forecast on improving lab tools demand

Aug 26, 2026, 4:33 PM EDT - 2 days ago

Agilent raises annual profit forecast on improving lab tools demand

Agilent Technologies Earnings Call Transcript: Q3 2026

Aug 26, 2026, 4:30 PM EDT - 2 days ago

Agilent Technologies Earnings Call Transcript: Q3 2026

Agilent Technologies Earnings release: Q3 2026

Aug 26, 2026, 4:30 PM EDT - 2 days ago

Agilent Technologies Earnings release: Q3 2026

Agilent Technologies Slides: Q3 2026

Aug 26, 2026, 4:30 PM EDT - 2 days ago

Agilent Technologies Slides: Q3 2026

Agilent up 4% at $161 after Q3 earnings beat and guidance raise

2026-08-26T20:16:03.000Z - 2 days ago

Agilent up 4% at $161 after Q3 earnings beat and guidance raise

Agilent reports Q3 EPS $1.62, consensus $1.49

2026-08-26T20:12:00.000Z - 2 days ago

Agilent reports Q3 EPS $1.62, consensus $1.49

Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results

Aug 26, 2026, 4:05 PM EDT - 2 days ago

Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results

Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo

Jul 29, 2026, 8:00 AM EDT - 4 weeks ago

Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo

Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26

Jul 28, 2026, 4:15 PM EDT - 4 weeks ago

Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26

Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Jul 23, 2026, 8:00 AM EDT - 5 weeks ago

Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Agilent Increases Its Investment in HALO X-ray Technologies

Jul 20, 2026, 3:11 AM EDT - 5 weeks ago

Agilent Increases Its Investment in HALO X-ray Technologies

Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

Jul 14, 2026, 8:00 AM EDT - 6 weeks ago

Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

Jul 8, 2026, 8:00 AM EDT - 7 weeks ago

Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight

Jul 1, 2026, 8:00 AM EDT - 2 months ago

Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight

Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies

Jun 25, 2026, 8:06 AM EDT - 2 months ago

Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies

Agilent Completes Acquisition of Biocare Medical

Jun 25, 2026, 8:00 AM EDT - 2 months ago

Agilent Completes Acquisition of Biocare Medical

UMH PROPERTIES, INC. WELCOMES THE 21ST CENTURY ROAD TO HOUSING ACT: A MAJOR BOOST FOR AFFORDABLE MANUFACTURED HOUSING

Jun 24, 2026, 6:45 AM EDT - 2 months ago

UMH PROPERTIES, INC. WELCOMES THE 21ST CENTURY ROAD TO HOUSING ACT: A MAJOR BOOST FOR AFFORDABLE MANUFACTURED HOUSING

UMH

Tradeweb Announces Date for Second Quarter 2026 Financial Results

Jun 23, 2026, 2:00 PM EDT - 2 months ago

Tradeweb Announces Date for Second Quarter 2026 Financial Results

TW

Agilent Technologies Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 9:20 AM EDT - 3 months ago

Agilent Technologies Transcript: Jefferies Global Healthcare Conference 2026

Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation

Jun 3, 2026, 7:00 AM EDT - 3 months ago

Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation

Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma

Jun 2, 2026, 4:15 PM EDT - 3 months ago

Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma

Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory

May 28, 2026, 8:00 AM EDT - 3 months ago

Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory

Agilent Technologies Earnings Call Transcript: Q2 2026

May 27, 2026, 4:30 PM EDT - 3 months ago

Agilent Technologies Earnings Call Transcript: Q2 2026

Agilent Technologies Slides: Q2 2026

May 27, 2026, 4:30 PM EDT - 3 months ago

Agilent Technologies Slides: Q2 2026

Agilent Technologies Earnings release: Q2 2026

May 27, 2026, 4:30 PM EDT - 3 months ago

Agilent Technologies Earnings release: Q2 2026

Agilent Technologies Quarterly report: Q2 2026

May 27, 2026, 4:30 PM EDT - 3 months ago

Agilent Technologies Quarterly report: Q2 2026

Agilent raises 2026 profit forecast on strong demand for lab tools

May 27, 2026, 4:09 PM EDT - 3 months ago

Agilent raises 2026 profit forecast on strong demand for lab tools

Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results

May 27, 2026, 4:05 PM EDT - 3 months ago

Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results

Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control

May 26, 2026, 8:00 AM EDT - 3 months ago

Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control

Agilent Launches New GC Systems with GC Assist to Improve Laboratory Efficiency and Data Quality

May 26, 2026, 8:00 AM EDT - 3 months ago

Agilent Launches New GC Systems with GC Assist to Improve Laboratory Efficiency and Data Quality

Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis

May 22, 2026, 8:00 AM EDT - 3 months ago

Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis

Agilent Launches 1290 Infinity III Fluorescence Detector for Confident Trace Analysis at UHPLC Speed

May 21, 2026, 8:00 AM EDT - 3 months ago

Agilent Launches 1290 Infinity III Fluorescence Detector for Confident Trace Analysis at UHPLC Speed

Agilent Announces Cash Dividend of 25.5 Cents per Share

May 20, 2026, 4:27 PM EDT - 3 months ago

Agilent Announces Cash Dividend of 25.5 Cents per Share

Agilent to Supply Next Generation Alarm Resolution Technology to U.S. Airport Security Screening Checkpoints ahead of FIFA World Cup 2026

May 19, 2026, 8:00 AM EDT - 3 months ago

Agilent to Supply Next Generation Alarm Resolution Technology to U.S. Airport Security Screening Checkpoints ahead of FIFA World Cup 2026

Agilent to Participate in Jefferies Global Healthcare Conference

May 11, 2026, 4:15 PM EDT - 3 months ago

Agilent to Participate in Jefferies Global Healthcare Conference

Agilent Names Michael Buckner as Chief Legal Officer

May 4, 2026, 8:00 AM EDT - 4 months ago

Agilent Names Michael Buckner as Chief Legal Officer

Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27

Apr 28, 2026, 4:15 PM EDT - 4 months ago

Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27

Axion BioSystems and Agilent Technologies Resolve Litigation

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Axion BioSystems and Agilent Technologies Resolve Litigation

Agilent Showcases Cancer Research Solutions at AACR 2026

Apr 15, 2026, 8:00 AM EDT - 4 months ago

Agilent Showcases Cancer Research Solutions at AACR 2026

Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader

Apr 1, 2026, 8:00 AM EDT - 5 months ago

Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader

Agilent Technologies Slides: Corporate presentation

Mar 27, 2026, 7:00 AM EDT - 5 months ago

Agilent Technologies Slides: Corporate presentation

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma

Mar 26, 2026, 8:00 AM EDT - 5 months ago

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma

Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026

Mar 19, 2026, 8:00 AM EDT - 5 months ago

Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

Mar 11, 2026, 8:00 AM EDT - 6 months ago

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

Agilent to acquire Biocare Medical in $950 million all-cash deal

Mar 9, 2026, 3:09 AM EDT - 6 months ago

Agilent to acquire Biocare Medical in $950 million all-cash deal

Excellere Partners and GHO Capital Sell Biocare Medical to Agilent Technologies

Mar 9, 2026, 3:05 AM EDT - 6 months ago

Excellere Partners and GHO Capital Sell Biocare Medical to Agilent Technologies

Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions

Mar 9, 2026, 3:00 AM EDT - 6 months ago

Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions

Agilent Technologies Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 11:10 AM EST - 6 months ago

Agilent Technologies Transcript: TD Cowen 46th Annual Health Care Conference

Agilent reports in-line first quarter, says results hurt by US snowstorm

Feb 25, 2026, 5:24 PM EST - 6 months ago

Agilent reports in-line first quarter, says results hurt by US snowstorm

Agilent Technologies Earnings Call Transcript: Q1 2026

Feb 25, 2026, 4:30 PM EST - 6 months ago

Agilent Technologies Earnings Call Transcript: Q1 2026

Agilent Technologies Quarterly report: Q1 2026

Feb 25, 2026, 4:30 PM EST - 6 months ago

Agilent Technologies Quarterly report: Q1 2026

Agilent Technologies Earnings release: Q1 2026

Feb 25, 2026, 4:30 PM EST - 6 months ago

Agilent Technologies Earnings release: Q1 2026

Agilent Technologies Slides: Q1 2026

Feb 25, 2026, 4:30 PM EST - 6 months ago

Agilent Technologies Slides: Q1 2026

Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

Feb 25, 2026, 4:05 PM EST - 6 months ago

Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

Agilent to Participate in TD Cowen's 46th Annual Health Care Conference

Feb 23, 2026, 4:15 PM EST - 6 months ago

Agilent to Participate in TD Cowen's 46th Annual Health Care Conference

Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award

Feb 11, 2026, 8:00 AM EST - 7 months ago

Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)

Feb 11, 2026, 6:45 AM EST - 7 months ago

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)

Agilent Technologies Proxy statement: Proxy Filing

Feb 6, 2026, 7:00 AM EST - 7 months ago

Agilent Technologies Proxy statement: Proxy Filing

Agilent Technologies Proxy statement: Proxy Filing

Feb 6, 2026, 7:00 AM EST - 7 months ago

Agilent Technologies Proxy statement: Proxy Filing

Agilent Showcases Next‑Generation Automated Solutions at SLAS2026

Feb 4, 2026, 8:00 AM EST - 7 months ago

Agilent Showcases Next‑Generation Automated Solutions at SLAS2026

Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25

Feb 2, 2026, 4:15 PM EST - 7 months ago

Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25

Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System

Jan 23, 2026, 8:00 AM EST - 7 months ago

Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System

Agilent Technologies Proxy statement: Proxy Filing

Jan 23, 2026, 7:00 AM EST - 7 months ago

Agilent Technologies Proxy statement: Proxy Filing

Agilent Technologies Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 12:00 PM EST - 8 months ago

Agilent Technologies Transcript: 44th Annual J.P. Morgan Healthcare Conference

Agilent Technologies Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 12:00 PM EST - 8 months ago

Agilent Technologies Slides: 44th Annual J.P. Morgan Healthcare Conference

Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 16, 2025, 8:31 AM EST - 9 months ago

Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference

Agilent Technologies Transcript: Citi Annual Global Healthcare Conference 2025

Dec 4, 2025, 9:00 AM EST - 9 months ago

Agilent Technologies Transcript: Citi Annual Global Healthcare Conference 2025

Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight

Dec 1, 2025, 8:00 AM EST - 9 months ago

Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight

Top small-cap plays for 2026

Nov 25, 2025, 1:24 PM EST - 9 months ago

Top small-cap plays for 2026

COHR DG EW TXT VLO

Agilent Technologies Earnings Call Transcript: Q4 2025

Nov 24, 2025, 4:30 PM EST - 9 months ago

Agilent Technologies Earnings Call Transcript: Q4 2025

Agilent Technologies Annual report: Q4 2025

Nov 24, 2025, 4:30 PM EST - 9 months ago

Agilent Technologies Annual report: Q4 2025

Agilent Technologies Earnings release: Q4 2025

Nov 24, 2025, 4:30 PM EST - 9 months ago

Agilent Technologies Earnings release: Q4 2025

Agilent Technologies Slides: Q4 2025

Nov 24, 2025, 4:30 PM EST - 9 months ago

Agilent Technologies Slides: Q4 2025

Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results

Nov 24, 2025, 4:10 PM EST - 9 months ago

Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results

Agilent beats quarterly revenue estimates on strong demand for lab tools

Nov 24, 2025, 4:07 PM EST - 9 months ago

Agilent beats quarterly revenue estimates on strong demand for lab tools

Stocktwits52wHighs
Stocktwits52wHighs Aug. 27 at 4:31 PM
$A printed a new 52-week high today
0 · Reply
runitback349
runitback349 Aug. 27 at 2:08 PM
$A look at the monthly chart. Crazy set-up if it breaks out of the range
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 27 at 12:22 PM
$A (+2.1% pre) Agilent shares rise as strong Q3 results and improving demand support guidance upgrade https://ooc.bz/l/112464
0 · Reply
parcha
parcha Aug. 27 at 12:17 AM
Stocks making the biggest moves after hours: Nvidia, Salesforce, CrowdStrike, Urban Outfitters and more $A $IHI Agilent Technologies — The medical technology stock jumped 4% on a stronger-than-expected revenue report for its third quarter. Agilent said it brought in $1.88 billion in revenue, while analysts polled by FactSet forecast $1.84 billion, per FactSet. https://www.cnbc.com/2026/08/26/stocks-making-the-biggest-moves-after-hours-nvda-crm-crwd-urbn-and-more.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 · Reply
DonCorleone77
DonCorleone77 Aug. 26 at 11:52 PM
$VEEV $NTNX $OOMA $A $NVDA AFTER-HOURS MOVERS: Currently Higher After Earnings: - Okta (OKTA) up 20.5% - Salesforce (CRM) up 13.0% - Lantronix (LTRX) up 13.8% - Phibro Animal Health Corporation (PAHC) up 8.5% - CrowdStrike Holdings (CRWD) up 10.0% - Veeva Systems (VEEV) up 9.0% - Nutanix (NTNX) up 6.3% - Ooma, Inc. (OOMA) up 4.3% - Agilent Technologies (A) up 3.2% - NVIDIA (NVDA) up 4.3% - Everpure, Inc. (P) up 3.1% Currently Also Higher: - Tenable Holdings (TENB) up 7.4% after admission into S&P SmallCap 600 index - Funko (FNKO) up 6.3% after insider buy Currently Lower After Earnings: - HP Inc. (HPQ) down 9.1% - Urban Outfitters, Inc. (URBN) down 2.8% - Synopsys (SNPS) down 1.1% Currently Also Lower: - Wendy's Company (WEN) down 13.2% after Reuters report Trian is backing away from bid.
1 · Reply
Estimize
Estimize Aug. 26 at 10:57 PM
$A reported 1.62 EPS and 1,878 revenue for Q3. http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=A&utm_medium=ac
0 · Reply
EarningsInsider
EarningsInsider Aug. 26 at 9:46 PM
https://www.marketbeat.com/earnings/reports/2026-8-26-agilent-technologies-inc-stock/ $A Agilent Technologies Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 26 at 9:40 PM
$A Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $1.62 up 18.25% YoY • Reported revenue of $1.88B up 8.06% YoY • For fiscal year 2026, Agilent expects revenue between $7.49B and $7.51B, non-GAAP operating margin expansion over 130 basis points at midpoint, and non-GAAP EPS of $6.18 to $6.21.
0 · Reply
flychicken1991
flychicken1991 Aug. 26 at 8:54 PM
$A Positive (86%): Agilent's stock is likely to face upward price pressure as investors incorporate stronger reported demand, above-consensus quarterly results, and higher full-year guidance into forward earnings expectations. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/0af578bd4c16288a/a-agilent-technologies-beats-estimates-raises-guidance-on-strong-demand?utm_source=stocktwits&utm_medium=story_url
0 · Reply
DonCorleone77
DonCorleone77 Aug. 26 at 8:13 PM
$A Agilent raises FY26 EPS view to $6.18-$6.21, consensus $6.06 Raises FY26 revenue view to $7.49B-$7.51B, consensus $7.45B. Prior FY26 EPS guidance was $6.00-$6.10, revenue $7.39B-$7.49B.
0 · Reply
DonCorleone77
DonCorleone77 Aug. 26 at 8:12 PM
$A Agilent sees Q4 EPS $1.71-$1.74, consensus $1.71 Sees Q4 revenue $1.98B-$2.0B, consensus $1.97B
0 · Reply
DonCorleone77
DonCorleone77 Aug. 26 at 8:12 PM
$A Agilent reports Q3 EPS $1.62, consensus $1.49 Reports Q3 revenue $1.88B, consensus $1.84B. "Agilent's exceptional third-quarter performance reflects the sustained momentum created by our strategy, our execution discipline, and the compounding impact of the Ignite Operating System," said Agilent CEO Padraig McDonnell. "We are seeing improving end markets, stronger demand in key regions, and excellent customer response to our innovative product launches. All of this gives us confidence in our increased outlook and our ability to sustainably outperform our end markets."
0 · Reply
DonCorleone77
DonCorleone77 Aug. 26 at 7:47 PM
$A Agilent options imply 5.2% move in share price post-earnings Pre-earnings options volume in Agilent is 10.0x normal with calls leading puts 2:1. Implied volatility suggests the market is anticipating a move near 5.2%, or $7.96, after results are released. Median move over the past eight quarters is 2.7%.
0 · Reply
Estimize
Estimize Aug. 26 at 3:01 PM
$A reports after the close, Estimize Consensus +0.03 EPS and +13.48M Revs compared to WS http://www.estimize.com/a/fq3-2026?utm_content=pre
0 · Reply
TradingPlayground
TradingPlayground Aug. 26 at 1:53 PM
$A reports Aug 26 after close. Consensus EPS: 1.48. Price at 154.77, at 89.1% of the 52-week range (108.35–160.47). Off-exchange flow: 37.8% vs. a 60-session median of 24.4% — elevated ahead of the print. GEX positive: dealers net long gamma, dampening intraday swings. Weekly range still open — no confirmed exit. DOMINA tracks actual vs. consensus EPS quarter by quarter. tradingsuite.io
0 · Reply
AnalystKrishna
AnalystKrishna Aug. 25 at 6:13 AM
$A 5+ years of consolidation and trading between 95/100 - 153/160. Can invest few for short term target of 179.4 If on good earnings and if this crosses 180 then all is good for its investors and they can see the price rising to 252 in next 6 to 8 months. On not-so-expected earnings, this can again fallback to 134, 120, 110 and will rise again to 160. Short term ROI --> 17% Long term ROI --> 64.5%
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 21 at 6:31 PM
$A printed a new 52-week high today
0 · Reply
KingAJ6
KingAJ6 Aug. 21 at 4:12 PM
$SPPI $SPY $AAPL $A $MSFT 480P 8/21 @0.14
0 · Reply
stockanalysis_
stockanalysis_ Aug. 20 at 9:59 PM
After Hours Losers 1. $JZ -29.22% 2. $FLUX.X -19.62% 3. $YOUL -13.89% 4. $OSIS -13.79% 5. $A -13.32%
0 · Reply
CarolDonaldson311
CarolDonaldson311 Aug. 5 at 6:46 AM
$SYY $NTRA $A $ESLT $HMC Sysco leads food distribution, Natera dominates genetic testing, Agilent Technologies benefits from life science demand, Elbit Systems gains from defense spending, and Honda continues advancing hybrid and EV technologies.
0 · Reply
KateBlack770
KateBlack770 Aug. 3 at 2:45 PM
$WDAY $ED $IBKR $TEVA $A Workday leads enterprise software, Consolidated Edison provides stable utility income, Interactive Brokers benefits from trading activity, Teva continues restructuring, and Agilent Technologies leads life science instrumentation.
0 · Reply
Estimize
Estimize Aug. 3 at 2:12 PM
Wall St is expecting 1.49 EPS for $A Q3 [Reporting 08/26 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply